Contraindicated (1)pentobarbital will decrease the extent or influence of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital will lessen the level or impact of dasatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.pentobarbital will minimize the level or outcome of fosaprepitant by aff